Showing results (141-150 of 1,607) with videos related to

Sort By:
Pageof 161
JAMA Oncology|June 27, 2024
Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black IndividualsKemi M Doll, Mindy Pike, Julianna Alson, et al.
JAMA Oncology|January 26, 2023
Impact of Common Vitamin D-Binding Protein Isoforms on Supplemental Vitamin D3 and/or Calcium Effects on Colorectal Adenoma Recurrence Risk: A Secondary Analysis of a Randomized Clinical TrialDavid Corley Gibbs, Elizabeth L Barry, Veronika Fedirko, et al.
JAMA Oncology|December 29, 2022
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With CancerInna Y Gong, Abi Vijenthira, Melanie Powis, et al.
JAMA Oncology|November 23, 2022
Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical TrialJoseph M Unger, Amy Darke, Megan Othus, et al.
JAMA Oncology|November 22, 2019
Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical TrialDouglas W Arthur, Kathryn A Winter, Henry M Kuerer, et al.
JAMA Oncology|November 28, 2019
Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical CancerJyoti S Mayadev, Danielle Enserro, Yvonne G Lin, et al.
JAMA Oncology|November 28, 2019
Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical TrialYong Xia, Jun Li, Guanghua Liu, et al.
JAMA Oncology|November 1, 2019
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical TrialAndrea Cercek, Thomas Boerner, Benjamin R Tan, et al.
JAMA Oncology|July 8, 2021
Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of ERBB2-Positive Metastatic Breast CancerJosee-Lyne Ethier, Danielle Desautels, Andrew Robinson, et al.
JAMA Oncology|December 30, 2020
Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical TrialJunji Zhang, Yuqian Zhao, Yi Dai, et al.
Pageof 161